Related Experiment Video
Updated: Apr 14, 2026
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma
Insights
This guideline offers updated recommendations for managing hepatocellular carcinoma (HCC) in Korea, based on recent evidence and expert consensus for initial patient treatment.
Area of Science:
- Hepatology
- Oncology
- Clinical Practice Guidelines
Background:
- The Korean Liver Cancer Study Group and National Cancer Center first issued HCC management guidelines in 2003, revised in 2009.
- Significant research advancements in hepatocellular carcinoma diagnosis, staging, and treatment, particularly concerning Asian populations, have occurred since the last revision.
- Accumulated knowledge necessitates updated strategies for hepatocellular carcinoma management.
Purpose of the Study:
- To present a new, evidence-based guideline for the management of hepatocellular carcinoma (HCC).
- To provide recommendations for the initial treatment of patients with newly diagnosed HCC.
- To incorporate recent evidence and expert opinions tailored to Korean and Asian characteristics.
Main Methods:
- Development based on recent scientific evidence.
- Incorporation of expert opinions from the Korean Liver Cancer Study Group and National Cancer Center.
- Focus on diagnosis, staging, and treatment strategies for hepatocellular carcinoma.
Main Results:
- A comprehensive guideline for hepatocellular carcinoma (HCC) management.
- Recommendations for initial treatment strategies.
- Consideration of specific Asian and Korean patient characteristics.
Conclusions:
- The updated guideline reflects the latest evidence and expert consensus for HCC management.
- It aims to improve the initial treatment of patients diagnosed with hepatocellular carcinoma.
- The guideline addresses the unique aspects of HCC in the Korean population.
Abstract:
The guideline for the management of hepatocellular carcinoma (HCC) was first developed in 2003 and revised in 2009 by the Korean Liver Cancer Study Group and the National Cancer Center, Korea. Since then, many studies on HCC have been carried out in Korea and other countries. In particular, a substantial body of knowledge has been accumulated on diagnosis, staging, and treatment specific to Asian characteristics, especially Koreans, prompting the proposal of new strategies. Accordingly, the new guideline presented herein was developed on the basis of recent evidence and expert opinions. The primary targets of this guideline are patients with suspicious or newly diagnosed HCC. This guideline provides recommendations for the initial treatment of patients with newly diagnosed HCC.
More Related Videos
03:23Fluorescent Laparoscopic Central Hepatectomy for Liver Cancer Using Indocyanine Green Negative Staining
Published on: March 17, 2023
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
